Cytos Biotechnology Ltd: CYT003-QbG10 phase IIb data presented at EAACI 2010 in London, UK

Schlieren, (PresseBox) - Cytos Biotechnology Ltd (SIX:CYTN) is pleased to inform you about two presentations at the 29th Congress of the European Academy of Allergy and Clinical Immunology in London, UK from June 5-9, 2010.

Prof. Klimek, the principal investigator of the study, will present 'Treatment with CYT003-QbG10, an allergenfree immunomodulator, reduces allergic symptoms in patients with rhinoconjunctivitis due to house dust mite allergy' on Sunday, June 6, 2010, 10.30 am - 12.00 pm.

Dr. Bachmann, CSO of Cyots Biotechnology, will present 'Bacteriophage coupled Fel d1 a novel immunotherapy agent for cat allergy' on Tuesday, June 8, 2010 at 10.30 am.

Press releases you might also be interested in

Weitere Informationen zum Thema "Forschung und Entwicklung":

Neue Tools für Deep Learning und autonomes Fahren

Ma­thWorks stellt Re­lea­se 2018a (R2018a) mit ei­ner Rei­he neu­er Funk­tio­nen in MAT­LAB und Si­mu­link vor. Dar­un­ter fal­len u.a. die Pre­dic­ti­ve Main­tenan­ce Tool­box zum Ent­wer­fen und Tes­ten von Al­go­rith­men für die Zu­stands­über­wa­chung und Pre­dic­ti­ve Main­tenan­ce und das Ve­hi­c­le Dy­na­mics Block­set für die Mo­del­lie­rung und Si­mu­la­ti­on von Fahr­zeug­dy­na­mik in ei­ner vir­tu­el­len 3D-Um­ge­bung.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.